In the 1930’s Arthur Fox, a chemist at Dupont, synthesized phenylthiocarbamide (PTC). While transferring the compound to a bottle he generated a cloud of PTC dust which elicited a dramatic response in his lab mate. Although Fox tasted nothing, his colleague, C. R. Noller, complained that the dust was intensely bitter. (Arthur L. Fox’s original 1932 paper, The Relationship Between Chemical Constitution and Health, can be read at the web site of the journal, The Proceedings of the National Academy of Science.
Since Fox's serendipitous discovery, variation in the ability to taste PTC (and other related bitter compounds such as those found in broccoli!) has become one of the most studied of human genetic traits. On the surface, PTC sensitivity appears to be inherited as a simple Mendelian trait with two alleles, T for taster and t for nontaster; in reality its inheritance is much more complicated. Today we know that PTC sensitivity is mediated by the PTC gene (aka TAS2R38) that encodes a bitter taste receptor (a heteromeric G-protein coupled receptor to be exact) which is found on the surface of cells of the tongue. Kim et. al. (2003), published a ground-breaking paper entitled, Positional Cloning of the Human Quantitative Trait Locus Underlying Taste Sensitivity to Phenylthiocarbamide, in the journal Science, which can be downloaded in PDF form through the Wellesley College Library's on-line subscription to Science. To learn even more about the PTC gene, check out the review article by Kim and Drayna (2006) and another review by S. Wooding (2006). In class we will view the video “The Science of Picky Eaters”.
Additional studies of the PTC gene in humans across the globe have revealed that there are two common alleles, taster and nontaster; however, there are at least nineteen other rare alleles that affect the taster phenotype. These different forms of the gene code for proteins that vary in their ability to bind bitter compounds such as PTC. The two common alleles of the PTC gene differ by three single nucleotide polymorphisms (SNPs) which are shown below. SNPs (pronounced “snips”) represent the simplest type of genetic variation between individuals. A SNP refers to a specific location in the genome where different people have been shown to have a different nucleotide. If more than one percent of the population has a different base at a particular location, that location is considered a SNP. If less than one percent of the population has a different base, it is considered a mutation.
Polymorphic Sites in the PTC Taster Gene
| Nucleotide position || Taster || Nontaster
The common nontaster allele (or haplotype) has a G at nucleotide position 145 (G145), T at position 785 (T785) and A at position 886 (A886). This nontaster allele produces a polypeptide with alanine, valine and isoleucine at these sites and therefore is referred to as the AVI allele. The common taster allele C145, C785, and G886, produces a polypeptide with proline, alanine, and valine at these sites, and is referred to as the PAV allele.
The SNP at position 785 is useful for determining your PTC genotype since the taster sequence in this region forms a Fnu4H1 restriction site while replacing C785 with T785 in the nontaster allele eliminates this restriction site. (A restriction site is a specific DNA sequence that is recognized and cleaved by a specific restriction enzyme or endonuclease.) There are two other Fnu4H1 restriction sites within the PTC gene, but we will use primers specifically designed to bind to regions flanking the one polymorphic Fnu4H1 site while excluding the other two. Using these primers in a polymerase chain reaction (PCR) generates a 303 base pair (bp) fragment. Restriction digestion of this PCR product with Fnu4H1 will yield one 303 bp fragment for the nontaster allele and two shorter fragments (65 bp and 239 bp) for the taster allele. Visit the Dolan DNA center web site at  to learn more about PCR and see an animation of how it works.
Fnu4H1 Restriction Site
N can be any of the 4 bases
Figure 1. Sequence of the Taster allele of the PTC gene. The 3 SNPs are highlighted in blue with the nucleotide found in the nontaster allele shown below the taster. The position of the forward and reverse PCR primers are shown in green and red, respectively. The Fnu4H1 site you will exploit for genotyping is underlined in black at position 785.
In two-weeks of lab experiments and a third lab meeting of discussion, you will be provided with a phenotype and determine the genotype at the PTC locus of a hypothetical Wellesley student. You will also explore some of the ethical issues surrounding personal genomics and learn more about writing a scientific paper. In the first week you will be assigned a PTC phenotype. You will also begin the process of determining your assigned PTC genotype by extracting and purifying human PTC DNA contained within bacterial plasmids (a plasmid is a circular piece of DNA). You will then use the polymerase chain reaction (PCR) to amplify a region of DNA that contains a SNP in the PTC gene. PCR is a technique which exploits in vitro DNA replication by a heat stable DNA polymerase to produce millions of copies of a specific DNA sequence. In addition, we will watch a video about some of the ethical issues related to the use of SNPs and other genetic information. In the second lab you will determine your assigned PTC genotype by digesting your PCR product with the restriction enzyme Fnu4H1 which cuts the taster variant of this SNP but not the nontaster variant and analyzing the products by agarose gel electrophoresis. You will analyze the course data and make figures in preparation for a data analysis meeting. You will also outline your introduction and discussion sections to use in an in-lab workshop to prepare you for writing a scientific paper on your findings.
Lab 6 - Taster SNP Week 1
PART I: DNA extraction and purification (using QIAprep® Spin Miniprep Kit from Qiagen)
You will use a kit to isolate bacterial plasmid DNA (containing part of the human PTC gene). You will chemically break these cells open and use a silica-based spin column to separate the DNA from the other cellular components.
- Your instructor will assign you a number and a TASTER phenotype defined as either T (taster), NT (non-taster), or PT (partial taster). Record your assigned number and phenotype in your lab notebook so you don't forget them! You will need to remember your number so you can record your genotype results next to the phenotype results you have just obtained.
- You will be provided with a bacterial cell pellet in a 1.5-mL microfuge tube. Be sure that this tube has the same number that you were just assigned.
- Resuspend the pelleted bacterial cells in 250 μL of Buffer P1 (resuspension buffer) by vortexing or pipetting up and down until no cell clumps remain. Check with your instructor to ensure that you have resuspended the cells properly.
- Add 250 μL of Buffer P2 (lysis buffer) and mix thoroughly by gently inverting the tube 6 times. Do NOT vortex or the DNA will be sheared. Be sure that the solution is viscous and slightly clear before proceeding to the next step. In any case, do not let the lysis reaction proceed for more than five minutes.
- Add 350 μL of Buffer N3 (neutralization buffer) and mix immediately and thoroughly by inverting the tube 6 times. The solution should become cloudy.
- Centrifuge for 10 minutes at 13,000 rpm in a table-top microcentrifuge. A compact white pellet will form along the side of the tube.
- Label a QIAprep spin column with your number while you are waiting for the centrifugation step to be done.
- Apply the supernatent from the step 6 to your labeled QIAprep spin column by decanting.
- Centrifuge for 30 seconds at 13,000 rpm and discard the flow-through by dumping the contents of the collection tube into your liquid waste container.
- Wash the QIAprep spin column by adding 500 μL of Buffer PB (to wash away trace nucleases) and centrifuging at 13,000 rpm for 30 seconds. Discard the flow-through by dumping the contents of the collection tube into your liquid waste container.
- Wash the QIAprep spin column by adding 750 μL of Buffer PE and centrifuging at 13,000 rpm for 30 seconds. Discard the flow-through by dumping the contents of the collection tube into your liquid waste container.
- Centrifuge the QIAprep spin column for an additional 1 minute to remove any residual wash buffer. Residual ethanol from Buffer PE may inhibit the your PCR reaction so it is very important that you discard the flow-through in step 11 before proceeding with this step.
- Discard the collection tube and place the QIAprep column in a clean labeled 1.5 ml microcentrifuge tube. To elute the DNA from the QIAprep column, add 50 μL Buffer EB (10mM Tris-Cl, pH 8.5) to the center of the QIAprep spin column. Be careful not to touch the membrane with your pipette tip. Let stand 1 minute and then centrifuge at 13,000 rpm for 1 minute. You now have purified bacterial plasmid DNA containing a region of the human PTC gene.
PART II: Dilution of your DNA for use in the PCR reaction
You probably purified between 5 and 15 ug of plasmid DNA! Since it is ideal to use less than 1 ng of plasmid DNA in a PCR reaction, you will need to make a 1/10,000 dilution of your DNA in water. You could add 1 μL of plasmid DNA to 9,999 ul of water, but this would not be a very accurate way to make a 1/10,000 dilution. So, you will set up a series of dilutions to obtain your desired final dilution.
- Begin by making 1000 μL of a 1/100 dilution of your plasmid in water. To do this, you should add _____ μL of plasmid DNA to ______ μL of water. Using your 1/100 dilution, then make 1000 μL of a 1/10,000 dilution by adding ______ μL of your 1/100 dilution to _______ μL of water. You now have a 1/10,000 dilution of plasmid DNA and you will use this in PART III.
- Store your DNA on ice until you are ready to set up the PCR reaction.
PART II: PCR of your PTC gene (using PuRe Taq Ready-To-Go Master Mix beads (GE Healthcare)
Next, you will set up a polymerase chain reaction (PCR) designed to amplify from your extracted DNA the region of the PTC gene which contains the middle SNP (the one which creates a Fnu4H1 site in the taster allele). We need to use PCR so that we will have enough sample to allow us to visualize the DNA on a gel. The forward and reverse priming sites for our reactions are shown in Figure 1. In your notebook record the sequences of the forward and reverse primers. Use the convention of writing the primer sequence beginning with the 5’ end. Have your instructor check your sequences before proceeding.
- Locate a PCR tube, containing a master mix bead. Use a permanent marker to label the top of the tube with your student number. One partner in each group will also prepare a control DNA sample for PCR in addition to her own DNA. She will obtain 2 PCR tubes and label one with her student number and the other will be labeled C (for Control). The control DNA was extracted from a PTC Taster heterogygote who is, presumably, PVA/AVI. Marvel at the size of these tubes. “Master mix” is the commonly used term for this subset of the PCR components: it contains TAQ polymerase, dNTPs, and buffer. In this case, the components have been dried into a bead, so you’ll dissolve the bead into solution using your primers and DNA. Be especially careful with the PCR tubes. The walls are very thin and easy to damage.
- Tap the bottom of the tubes, very gently, on your bench to get the bead of reagents into the bottom of the tube BEFORE you open it! Pipette 20 μL of primers into each PCR tube. The two primers (one forward and one reverse primer) necessary to replicate both strands of your DNA are included in this reagent. The final concentration of each primer in the PCR tube will be 0.2 μM.
- Very carefully, pipette 5 μL of your 1/10,000 dilution of plasmid DNA into the appropriate PCR tube. If you are doing the control, go to the instructor's bench and ask him/her to pipette 5 μL of control DNA into your PCR tube labeled C.
- Mix the contents well by gently flicking the bottom of the tube. Then, vortex the tubes gently (at a vortex speed of 3) until the beads have gone completely into solution. The contents of the tubes should be clear.
- Using the centrifuge located next to the PCR machine, microfuge the tubes briefly (5 seconds) to get all the contents to the bottom. You will need to use adapters to microfuge these tiny tubes; the microcentrifuge next to the PCR machine is outfitted with these adaptors.
- Follow the instructions of your lab instructor for loading your samples into the PCR machine (called a “thermal cycler”). Your instructor will tell you how to record the location of your tubes in the thermal cycler on the template provided.
- Your lab instructor will return to lab after the PCR cycles are complete and transfer your PCR reactions into the freezer for storage.
Here is the cycle we will use for your samples:
First, there is an initial step for 10 minutes at 95C, to make sure all the DNA strands are disassociated to begin with.
This is followed by 40 cycles with the following pattern:
1 minute at 95C, for “melting” the DNA
1 minute at 55C, for annealing the primers to the single stranded DNA
1 minute at 72C, for synthesizing new DNA
There is then a 10 minute stage at 72C, to complete whatever synthesis has been started.
Finally, the tubes are chilled at 4C until someone moves them to the freezer for longer term storage.
PART IV. SNPs and bioethics
- As a class we will view a short video of a Nova scienceNOW episode that explores some of the ethical and policy issues that stem from the use of SNPs and other forms of genetic testing for medical diagnosis and assessment of genetic risk. Movie can be accessed at : NOVA Science NOW
- Read the following background information on restriction enzymes found at: SNP Restriction Enzymes and on gel electrophoresis at: Gel Electrophoresis.
- Read background information on SNPs in your textbook, pp. 678-684.
- Read the Abstract and Introduction of the following article, Wooding et al., Natural Selection and Molecular Evolution in PTC, a Bitter-Taste Receptor Gene. Am. J. Hum. Genet. 74:637–646, 2004. | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1181941/?tool=pubmed You should bring a hard copy of this article to lab next time.
- Read the following background information on ethical issues in Direct To Consumer genetic testing:
The Genetics Home Reference entries on:
direct-to-consumer genetic testing [(http://www.ghr.nlm.nih.gov/handbook/testing/directtoconsumer)]
test validity [(http://www.ghr.nlm.nih.gov/handbook/testing/validtest)]
test interpretation [(http://www.ghr.nlm.nih.gov/handbook/testing/interpretingresults)]
benefits of DTC [(http://www.ghr.nlm.nih.gov/handbook/testing/benefits)]
risks and limitations of DTC [(http://www.ghr.nlm.nih.gov/handbook/testing/riskslimitations)]
PUBLIC HEALTH: A Case Study of Personalized Medicine by S. H. Katsanis, G. Javitt, and K. Hudson,published in
Science, 4 April 2008 320: 53-54 [DOI: 10.1126/science.1156604] (in Policy Forum) found
AMA DTC genetic testing policy recommendations at: (http://www.dnapolicy.org/news.enews.article.nocategory.php?action=detail&newsletter_id=35&article_id=156)
The Answers to the following questions will be turned in at the beginning of Lab 7. You may download a .doc file of these questions here Media:Taster_DTC_questions110112_S12.doc to use as a template for your answers.
1. Think about the results you expect from next week's electrophoretic separation. After considering all you now know about PTC gene polymorphisms, draw the expected migration locations of the Fnu4H1 digested PCR product obtained from a homozygous PAV/PAV(left lane), a homozygous AVI/AVI (center lane) and a heterozygote PAV/AVI(right lane) on a diagram of an agarose gel (template shown below).
2. Answer the following questions:
a. Define the following terms:
single nucleotide polymorphism (SNP)
DTC genetic testing
b. What is the American Medical Association's position on DTC?
c. Summarize the American College of Medical Genetics recommendations on DTC genetic testing.
d. List 2 potential benefits and 2 potential risks/concerns of DTC genetic testing.
e. Analytically valid tests are available for variants in the CYP450 genes. Are these tests clinically valid? Do they have clinical utility?